Sun, Merck in generic drugs JV for emerging markets

  • 2:29
  • Published On: April 11, 2011
Cinema View
Embed
Indian drug major Sun Pharma has entered into a manufacturing and marketing tie-up with US pharma firm Merck’s Indian arm MSD Pharma to develop, manufacture and market generic drugs in emerging markets. The markets on their radar include Asia Pacific, Latin America, Eastern Europe, Middle East and Africa.

Related Videos

Sun Pharma Q4 Profit In Line With Estimates
May 26, 2023 0:35
Drug Major Sun Pharma Hit By Ransomware Attack
March 27, 2023 1:53
India Clears 2 New Vaccines And Merck's Covid Pill
December 28, 2021 1:29
Game-Changing Anti-Covid Pills Could Be Cleared Soon And Other Top Stories
November 11, 2021 1:7:56
Nifty Hits 11,600, Sensex Opens Above 38,400 For First Time
August 23, 2018 0:41
Sensex, Nifty Open On A Flat Note
July 05, 2017 1:45
Sensex Opens On Weak Note, Sun Pharma Shares Outperform
June 30, 2017 3:14
RIL, Bank Of Baroda, SBI Among Top Picks: Niraj Dalal
February 08, 2017 34:50
Accumulate Pharma Stocks: Sajiv Dhawan
November 10, 2016 35:15
Accumulate Sun Pharma At Current Levels: Sumeet Bagadia
November 08, 2016 13:23
Prabhudas Lilladher's View On Sun Pharma
November 07, 2016 13:05
Buy Sun Pharma For Long Term, Says TS Harihar
November 07, 2016 29:22
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination